Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
MiddleBrook Pharmaceuticals, Inc. (NASDAQ: MBRK) (“MiddleBrook” or the “Company”) has filed a voluntary petition (the...
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) today announced that James H. Cavanaugh, Ph.D., Martin A. Vogelbaum and Harold...
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) today announced that it has entered into an agreement with DoctorDirectory.com...
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) today announced its 2009 fourth quarter and full-year results, that it is...
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) announced today that it is partnering with DoctorDirectory.com, Inc...
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) announced today that on Dec. 31, 2009, it granted options to purchase a total of...
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) today announced a reduction of its field sales force and corporate staff...
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) today announced its financial and operational results for the quarter ended...
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) is scheduled to announce its results for the 2009 third quarter on Thursday...
MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), the maker of the first and only FDA-approved once-daily amoxicillin, MOXATAG...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지